Could This Be Novartis' Next Blockbuster Medicine?

Could This Be Novartis' Next Blockbuster Medicine?

Source: 
Motley Fool
snippet: 
  • Iptacopan aims to treat patients with a life-threatening blood disease.
  • If approved, the indication could top $1 billion in sales for the drugmaker.
  • The stock is trading at a discounted valuation compared to its peers.